22 June 2020 | News
A document edited by the organization’s Subregional Headquarters in Mexico indicates that intellectual property rules have increased the cost of access to some medicines and can jeopardize full enjoyment of the right to health, which is an especially relevant issue at this time of the COVID-19 pandemic.
